Integrated Human-Relevant Platforms for Preclinical Research

​

NAMina Bio structures and integrates and coordinates advanced human-relevant technologies into coherent preclinical research programs.

 

Through strategic collaborations with specialized technology partners, we integrate 3D bioprinting, organoid systems, microphysiological platforms, multi-omics profiling, and data-driven analytics to support predictive experimental design across disease areas.

​

​

Our Core Platform Capabilities

 

3D Bioprinting 

​

NAMina deploys high-resolution 3D bioprinting systems for the fabrication of reproducible tissue models using defined bioinks and matrix compositions.

​

Capabilities include:

​

• Spatially controlled 3D tissue architecture design
• Tunable extracellular matrix environments
• Structured co-culture modeling (e.g., tumor–stromal systems)
• Reproducible construct design for comparative studies

​

These systems are suitable for mechanistic studies, drug response profiling, and matrix-dependent phenotype analysis. Bioprinted models are selected and configured according to biological hypothesis and translational objectives.

​

Organoid-Based Modeling

​

NAMina integrates patient-derived or engineered organoid systems within structured experimental frameworks.

​

Capabilities include:

​

• Establishment and expansion of organoid cultures
• Drug sensitivity and resistance assays
• Heterogeneity and clonal response analysis
• Combination with defined matrix environments​

​

Organoid platforms can be combined with bioprinted scaffolds or integrated into dynamic perfusion systems when required. Organoid systems are incorporated within broader translational study designs.

​

Organ-on-Chip & Microphysiological Systems

​

Through collaboration with microfluidic and chip-based platform providers, NAMina supports dynamic culture environments that introduce perfusion, shear stress, and multi-compartment interactions.

​

Capabilities include:

​

• Controlled perfusion-based culture
• Modeling of immune–tissue interactions
• Vascularized or multi-compartment configurations
• Integration of 3D constructs into microfluidic environments

​

These systems support functional readouts beyond static culture models. Platform selection depends on experimental endpoints and physiological complexity required.

​

Matrix & Microenvironment Engineering

​

NAMina integrates defined synthetic and tunable extracellular matrix systems to reduce variability and improve reproducibility.

​

Capabilities include:

​

• Controlled biochemical composition
• Mechanical stiffness modulation
• Defined ligand presentation
• Reduction of animal-derived matrix variability

​

Matrix engineering is integrated across 3D bioprinting and organoid platforms. Matrix parameters are selected based on disease biology and assay requirements.

​

Multi-Omics & Molecular Profiling

​

NAMina integrates sequencing and molecular profiling workflows into experimental design.

​

Capabilities include:

​

• Bulk and targeted sequencing
• Gene expression profiling
• Variant analysis
• Experimental design alignment with downstream bioinformatic analysis

​

Molecular profiling and data generation are aligned with experimental design to enable mechanistic insight and informed translational decision-making.

​

Data Integration & Translational Analytics

​

Data outputs from phenotypic assays and molecular profiling are organized within structured analytical frameworks.

​

Capabilities include:

​

• Multi-layer dataset integration
• Comparative analysis across conditions
• Biomarker discovery support
• Structured reporting for decision-making

​

Analytical workflows are tailored to experimental objectives and translational milestones.

​

​

​